id,name,comment,phosphosite,uniprot,PMID,pdb_id3081,Akt,"Found in the C-terminal hydrophobic motif. Phosphorylation at this site by mTORC2 stimulates Akt activity (<a href='http://pubmed.org/pubmed/15718470' target='_blank' title='Open in PubMed'>Sarbassov et al., 2005</a>).",S474,Q60823,9445477,1p6s31272,Akt,"Found in the activation loop of the kinase domain and is phosphorylated by PDK1 (<a href='http://pubmed.org/pubmed/9094314' target='_blank' title='Open in PubMed'>Alessi et al., 1997</a>; <a href='http://pubmed.org/pubmed/9445477' target='_blank' title='Open in PubMed'>Stephens et al., 1998</a>; <a href='http://pubmed.org/pubmed/9228007' target='_blank' title='Open in PubMed'>Stokoe et al., 1997</a>). This precedes phosphorylation at a second site (S474) for complete activation (e.g., <a href='http://pubmed.org/pubmed/23684622' target='_blank' title='Open in PubMed'>Humphrey et al., 2013</a>).",T309,Q60823,15718470,1p6s10125,AS160,"Promotes 14-3-3 binding (although T649 is the primary binding site). Suggested to disrupt the GTPase-activating (GAP) function of AS160 and promote translocation of the GLUT4 glucose transporter to the plasma membrane, increasing glucose uptake (<a href='http://pubmed.org/pubmed/12637568' target='_blank' title='Open in PubMed'>Sano et al., 2003</a>; <a href='http://pubmed.org/pubmed/16880201' target='_blank' title='Open in PubMed'>Ramm et al., 2006</a>; <a href='http://pubmed.org/pubmed/17617058' target='_blank' title='Open in PubMed'>Geraghty et al., 2007</a>).",S324,Q8BYJ6,"12637568, 17617058",3qyb10128,AS160,"Promotes 14-3-3 binding (although T649 is the primary binding site). Suggested to disrupt the GTPase-activating (GAP) function of AS160 and promote translocation of the GLUT4 glucose transporter to the plasma membrane, increasing glucose uptake (<a href='http://pubmed.org/pubmed/12637568' target='_blank' title='Open in PubMed'>Sano et al., 2003</a>; <a href='http://pubmed.org/pubmed/16880201' target='_blank' title='Open in PubMed'>Ramm et al., 2006</a>; <a href='http://pubmed.org/pubmed/17617058' target='_blank' title='Open in PubMed'>Geraghty et al., 2007</a>).",S348,Q8BYJ6,"12637568, 17617058",3qyb10126,AS160,"Promotes 14-3-3 binding (although T649 is the primary binding site). Suggested to disrupt the GTPase-activating (GAP) function of AS160 and promote translocation of the GLUT4 glucose transporter to the plasma membrane, increasing glucose uptake (<a href='http://pubmed.org/pubmed/12637568' target='_blank' title='Open in PubMed'>Sano et al., 2003</a>; <a href='http://pubmed.org/pubmed/16880201' target='_blank' title='Open in PubMed'>Ramm et al., 2006</a>; <a href='http://pubmed.org/pubmed/17617058' target='_blank' title='Open in PubMed'>Geraghty et al., 2007</a>).",S595,Q8BYJ6,"12637568, 19897488",3qyb32814,AS160,"Promotes 14-3-3 binding (although T649 is the primary binding site). Suggested to disrupt the GTPase-activating (GAP) function of AS160 and promote translocation of the GLUT4 glucose transporter to the plasma membrane, increasing glucose uptake (<a href='http://pubmed.org/pubmed/12637568' target='_blank' title='Open in PubMed'>Sano et al., 2003</a>; <a href='http://pubmed.org/pubmed/16880201' target='_blank' title='Open in PubMed'>Ramm et al., 2006</a>; <a href='http://pubmed.org/pubmed/17617058' target='_blank' title='Open in PubMed'>Geraghty et al., 2007</a>).",T649,Q8BYJ6,"12637568, 16880201, 17617058",3qyb26140,BAD,"Promotes 14-3-3 binding, preventing BAD from heterodimerising with Bcl-XL, thus promoting cell survival and inhibiting apoptosis (<a href='http://pubmed.org/pubmed/8929531' target='_blank' title='Open in PubMed'>Zha et al., 1996</a>; <a href='http://pubmed.org/pubmed/10574959' target='_blank' title='Open in PubMed'>Tan et al., 1999</a>).",S112,Q61337,"8929531, 10574959",2bzw26145,BAD,"Promotes 14-3-3 binding, preventing BAD from heterodimerising with Bcl-XL, thus promoting cell survival and inhibiting apoptosis (<a href='http://pubmed.org/pubmed/8929531' target='_blank' title='Open in PubMed'>Zha et al., 1996</a>; <a href='http://pubmed.org/pubmed/9346240' target='_blank' title='Open in PubMed'>Datta et al., 1997</a>).",S136,Q61337,"8929531, 9346240",2bzw7591,Brf1,"Promotes 14-3-3 binding. This impairs its role in degrading mRNA molecules that contain AU-rich elements. 14-3-3 binding also protects Brf1 from degradation, perhaps to enable rapid mRNA decay once insulin stimulus is removed (<a href='http://pubmed.org/pubmed/15538381' target='_blank' title='Open in PubMed'>Schmidlin et al., 2004</a>; <a href='http://pubmed.org/pubmed/17030608' target='_blank' title='Open in PubMed'>Benjamin et al., 2006</a>).",S92,P23950,"15538381, 17030608",1rgo8254,Edc3,"Promotes 14-3-3 binding, which impairs its role in mRNA decay and translation repression at p-bodies (<a href='http://pubmed.org/pubmed/20051463' target='_blank' title='Open in PubMed'>Larance et al., 2010</a>). This provides one avenue for insulin to increase protein synthesis.",S161,Q8K2D3,20051463,3d3j8828,Eif4b,"p70S6K phosphorylates eIF4B at this site, which promotes association with the eIF3 scaffold in the translation pre-initiation complex. This enhances the helicase activity of eIF4A, melting inhibitory secondary structures in the 5' UTR of mRNAs. This enables the 40S ribosomal subunit to bind and initiate translation (<a href='http://pubmed.org/pubmed/15071500' target='_blank' title='Open in PubMed'>Raught et al., 2004</a>; <a href='http://pubmed.org/pubmed/16286006' target='_blank' title='Open in PubMed'>Holz et al., 2005</a>).",S422,Q8BGD9,"15071500, 16286006",2j7613766,Eif4ebp1,"mTORC1 phosphorylates EIF4EBP1 (4E-BP1) at several residues. This causes 4E-BP1 to dissociate from eIF4E, which enables eIF4E to bind the 5' cap of mRNAs, resulting in the initiation of translation (<a href='http://pubmed.org/pubmed/10779345' target='_blank' title='Open in PubMed'>Mothe-Satney et al., 2000</a>; <a href='http://pubmed.org/pubmed/9405468' target='_blank' title='Open in PubMed'>Brunn et al., 1997</a>).",S64,Q60876,10779345,3m9333654,Eif4ebp1,"mTORC1 phosphorylates EIF4EBP1 (4E-BP1) at several residues. This causes 4E-BP1 to dissociate from eIF4E, which enables eIF4E to bind the 5' cap of mRNAs, resulting in the initiation of translation (<a href='http://pubmed.org/pubmed/10779345' target='_blank' title='Open in PubMed'>Mothe-Satney et al., 2000</a>; <a href='http://pubmed.org/pubmed/9405468' target='_blank' title='Open in PubMed'>Brunn et al., 1997</a>).",T36,Q60876,10779345,3m9333657,Eif4ebp1,"mTORC1 phosphorylates EIF4EBP1 (4E-BP1) at several residues. This causes 4E-BP1 to dissociate from eIF4E, which enables eIF4E to bind the 5' cap of mRNAs, resulting in the initiation of translation (<a href='http://pubmed.org/pubmed/10779345' target='_blank' title='Open in PubMed'>Mothe-Satney et al., 2000</a>; <a href='http://pubmed.org/pubmed/9405468' target='_blank' title='Open in PubMed'>Brunn et al., 1997</a>).",T45,Q60876,10779345,3m9323370,eNOS,"Activates eNOS, which increases the production of nitric oxide, a signaling molecule that plays a role in numerous processes including vasodilation (<a href='http://pubmed.org/pubmed/10376603' target='_blank' title='Open in PubMed'>Dimmeler et al., 1999</a>).",S1176,P70313,10376603,3nos33117,Erk1,"MEK1/2 phosphorylates ERK1/2 within the 'activation lip' at T203/Y205 in ERK1 and T183/Y185 in ERK2 (<a href='http://pubmed.org/pubmed/1849075' target='_blank' title='Open in PubMed'>Payne et al., 1991</a>; <a href='http://pubmed.org/pubmed/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/pubmed/8626767' target='_blank' title='Open in PubMed'>Butch & Guan, 1996</a>; <a href='http://pubmed.org/pubmed/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>). Phosphorylation is favoured first at the tyrosine residue before the threonine residue (<a href='http://pubmed.org/pubmed/9228083' target='_blank' title='Open in PubMed'>Ferrell & Bhatt, 1997</a>; <a href='http://pubmed.org/pubmed/1628739' target='_blank' title='Open in PubMed'>Haystead et al., 1992</a>). This leads to activation of ERK1/2, enabling regulation of a diverse range of cellular responses to external stimuli (<a href='http://pubmed.org/pubmed/22569528' target='_blank' title='Open in PubMed'>Roskoski, 2012</a>). ERK1/2 also has the ability to autophosphorylate itself at these residues (<a href='http://pubmed.org/pubmed/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/pubmed/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>), but a 'gatekeeper' residue prevents this, maintaining low ERK1/2 activity in the absence of stimuli (<a href='http://pubmed.org/pubmed/17114285' target='_blank' title='Open in PubMed'>Emrick et al., 2006</a>).",T203,Q63844,"1849075, 8444886, 8626767, 7504457, 9228083, 1628739, 22569528, 17114285",4qtb37449,Erk1,"MEK1/2 phosphorylates ERK1/2 within the 'activation lip' at T203/Y205 in ERK1 and T183/Y185 in ERK2 (<a href='http://pubmed.org/pubmed/1849075' target='_blank' title='Open in PubMed'>Payne et al., 1991</a>; <a href='http://pubmed.org/pubmed/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/pubmed/8626767' target='_blank' title='Open in PubMed'>Butch & Guan, 1996</a>; <a href='http://pubmed.org/pubmed/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>). Phosphorylation is favoured first at the tyrosine residue before the threonine residue (<a href='http://pubmed.org/pubmed/9228083' target='_blank' title='Open in PubMed'>Ferrell & Bhatt, 1997</a>; <a href='http://pubmed.org/pubmed/1628739' target='_blank' title='Open in PubMed'>Haystead et al., 1992</a>). This leads to activation of ERK1/2, enabling regulation of a diverse range of cellular responses to external stimuli (<a href='http://pubmed.org/pubmed/22569528' target='_blank' title='Open in PubMed'>Roskoski, 2012</a>). ERK1/2 also has the ability to autophosphorylate itself at these residues (<a href='http://pubmed.org/pubmed/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/pubmed/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>), but a 'gatekeeper' residue prevents this, maintaining low ERK1/2 activity in the absence of stimuli (<a href='http://pubmed.org/pubmed/17114285' target='_blank' title='Open in PubMed'>Emrick et al., 2006</a>).",Y205,Q63844,"1849075, 8444886, 8626767, 7504457, 9228083, 1628739, 22569528, 17114285",4qtb31143,Erk2,"MEK1/2 phosphorylates ERK1/2 within the 'activation lip' at T203/Y205 in ERK1 and T183/Y185 in ERK2 (<a href='http://pubmed.org/pubmed/1849075' target='_blank' title='Open in PubMed'>Payne et al., 1991</a>; <a href='http://pubmed.org/pubmed/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/pubmed/8626767' target='_blank' title='Open in PubMed'>Butch & Guan, 1996</a>; <a href='http://pubmed.org/pubmed/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>). Phosphorylation is favoured first at the tyrosine residue before the threonine residue (<a href='http://pubmed.org/pubmed/9228083' target='_blank' title='Open in PubMed'>Ferrell & Bhatt, 1997</a>; <a href='http://pubmed.org/pubmed/1628739' target='_blank' title='Open in PubMed'>Haystead et al., 1992</a>). This leads to activation of ERK1/2, enabling regulation of a diverse range of cellular responses to external stimuli (<a href='http://pubmed.org/pubmed/22569528' target='_blank' title='Open in PubMed'>Roskoski, 2012</a>). ERK1/2 also has the ability to autophosphorylate itself at these residues (<a href='http://pubmed.org/pubmed/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/pubmed/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>), but a 'gatekeeper' residue prevents this, maintaining low ERK1/2 activity in the absence of stimuli (<a href='http://pubmed.org/pubmed/17114285' target='_blank' title='Open in PubMed'>Emrick et al., 2006</a>).",T183,P63085,"1849075, 8444886, 8626767, 7504457, 9228083, 1628739, 22569528, 17114285",3r6337331,Erk2,"MEK1/2 phosphorylates ERK1/2 within the 'activation lip' at T203/Y205 in ERK1 and T183/Y185 in ERK2 (<a href='http://pubmed.org/pubmed/1849075' target='_blank' title='Open in PubMed'>Payne et al., 1991</a>; <a href='http://pubmed.org/pubmed/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/pubmed/8626767' target='_blank' title='Open in PubMed'>Butch & Guan, 1996</a>; <a href='http://pubmed.org/pubmed/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>). Phosphorylation is favoured first at the tyrosine residue before the threonine residue (<a href='http://pubmed.org/pubmed/9228083' target='_blank' title='Open in PubMed'>Ferrell & Bhatt, 1997</a>; <a href='http://pubmed.org/pubmed/1628739' target='_blank' title='Open in PubMed'>Haystead et al., 1992</a>). This leads to activation of ERK1/2, enabling regulation of a diverse range of cellular responses to external stimuli (<a href='http://pubmed.org/pubmed/22569528' target='_blank' title='Open in PubMed'>Roskoski, 2012</a>). ERK1/2 also has the ability to autophosphorylate itself at these residues (<a href='http://pubmed.org/pubmed/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/pubmed/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>), but a 'gatekeeper' residue prevents this, maintaining low ERK1/2 activity in the absence of stimuli (<a href='http://pubmed.org/pubmed/17114285' target='_blank' title='Open in PubMed'>Emrick et al., 2006</a>).",Y185,P63085,"1849075, 8444886, 8626767, 7504457, 9228083, 1628739, 22569528, 17114285",3r634508,Foxo3a,"Promotes 14-3-3 binding, sequestering Foxo3a in the cytoplasm. This prevents its regulation of target genes, including those involved in apoptosis (<a href='http://pubmed.org/pubmed/10102273' target='_blank' title='Open in PubMed'>Brunet et al., 1999</a>; <a href='http://pubmed.org/pubmed/11864996' target='_blank' title='Open in PubMed'>Brunet et al., 2002</a>).",S252,Q9WVH4,"10102273, 11864996",2uzk4944,Grb10,"Enhances the stability of Grb10. Evidence suggests that this leads to feedback regulation of insulin signaling, either through the insulin receptor or by influencing mTORC1 (<a href='http://pubmed.org/pubmed/21659604' target='_blank' title='Open in PubMed'>Hsu et al., 2011</a>; <a href='http://pubmed.org/pubmed/21659605' target='_blank' title='Open in PubMed'>Yu et al., 2011</a>; <a href='http://pubmed.org/pubmed/24746805' target='_blank' title='Open in PubMed'>Liu et al., 2014</a>).",S503,Q60760,"21659604, 21659605, 24746805",3m7f24474,GSK3a,"GSK3a/b are unique kinases in that they require substrates to be phosphorylated at the residue +4 of the GSK3a/b target site. The GSK3 domain that binds this 'priming site' is occupied by the GSK3 N-terminus when S21/S9 (GSK3a/b) is phosphorylated by Akt (<a href='http://pubmed.org/pubmed/11430833' target='_blank' title='Open in PubMed'>Frame et al., 2001</a>). This leads to disrupted GSK3 activity (<a href='http://pubmed.org/pubmed/8524413' target='_blank' title='Open in PubMed'>Cross et al., 1995</a>). This not only derepresses glycogen synthesis (<a href='http://pubmed.org/pubmed/8816781' target='_blank' title='Open in PubMed'>Eldar-Finkelman et al., 1996</a>), for which GSK3 is named, but influences a wide range of cellular processes (reviewed in <a href='http://pubmed.org/pubmed/11579232' target='_blank' title='Open in PubMed'>Woodgett, 2001</a>).",S21,Q2NL51,"11430833, 8524413, 8816781, 11579232",2ow34288,GSK3b,"GSK3a/b are unique kinases in that they require substrates to be phosphorylated at the residue +4 of the GSK3a/b target site. The GSK3 domain that binds this 'priming site' is occupied by the GSK3 N-terminus when S21/S9 (GSK3a/b) is phosphorylated by Akt (<a href='http://pubmed.org/pubmed/11430833' target='_blank' title='Open in PubMed'>Frame et al., 2001</a>). This leads to disrupted GSK3 activity (<a href='http://pubmed.org/pubmed/8524413' target='_blank' title='Open in PubMed'>Cross et al., 1995</a>). This not only derepresses glycogen synthesis (<a href='http://pubmed.org/pubmed/8816781' target='_blank' title='Open in PubMed'>Eldar-Finkelman et al., 1996</a>), for which GSK3 is named, but influences a wide range of cellular processes (reviewed in <a href='http://pubmed.org/pubmed/11579232' target='_blank' title='Open in PubMed'>Woodgett, 2001</a>).",S9,Q9WV60,"11430833, 8524413, 8816781, 11579232",4nm05572,Gys,"GSK3 phosphorylates Gys at consecutive serines (S641, S645, S649, S653) in a C- to N-terminal direction - once S641 is phosphorylated, Gys activity is reduced (<a href='http://pubmed.org/pubmed/6249596' target='_blank' title='Open in PubMed'>Embi et al., 1980</a>; <a href='http://pubmed.org/pubmed/6772446' target='_blank' title='Open in PubMed'>Rylatt et al., 1980</a>; <a href='http://pubmed.org/pubmed/7759494' target='_blank' title='Open in PubMed'>Skurat & Roach, 1995</a>; <a href='http://pubmed.org/pubmed/8226927' target='_blank' title='Open in PubMed'>Wang & Roach, 1993</a>). Upon insulin stimulation, GSK3 is inhibited, derepressing Gys and thus stimulating glycogen synthesis (<a href='http://pubmed.org/pubmed/14745035' target='_blank' title='Open in PubMed'>Schafer et al., 2004</a>; <a href='http://pubmed.org/pubmed/22248338' target='_blank' title='Open in PubMed'>Roach et al., 2012</a>).",S641,Q9Z1E4,"6249596, 6772446, 7759494, 8226927, 14745035, 22248338",4kqm5575,Gys,"GSK3 phosphorylates Gys at consecutive serines (S641, S645, S649, S653) in a C- to N-terminal direction - once S641 is phosphorylated, Gys activity is reduced (<a href='http://pubmed.org/pubmed/6249596' target='_blank' title='Open in PubMed'>Embi et al., 1980</a>; <a href='http://pubmed.org/pubmed/6772446' target='_blank' title='Open in PubMed'>Rylatt et al., 1980</a>; <a href='http://pubmed.org/pubmed/7759494' target='_blank' title='Open in PubMed'>Skurat & Roach, 1995</a>; <a href='http://pubmed.org/pubmed/8226927' target='_blank' title='Open in PubMed'>Wang & Roach, 1993</a>). Upon insulin stimulation, GSK3 is inhibited, derepressing Gys and thus stimulating glycogen synthesis (<a href='http://pubmed.org/pubmed/14745035' target='_blank' title='Open in PubMed'>Schafer et al., 2004</a>; <a href='http://pubmed.org/pubmed/22248338' target='_blank' title='Open in PubMed'>Roach et al., 2012</a>).",S649,Q9Z1E4,"6249596, 6772446, 7759494, 8226927, 14745035, 22248338",4kqm6241,HSF1,"In response to growth factors, MAPK phosphorylates HSF1 at S307, which primes GSK3 to phosphorylate at S303 (<a href='http://pubmed.org/pubmed/8940068' target='_blank' title='Open in PubMed'>Chu et al., 1996</a>). This promotes 14-3-3 binding, sequestering HSF1 in the cytoplasm and thus repressing its transcriptional activity (<a href='http://pubmed.org/pubmed/12917326' target='_blank' title='Open in PubMed'>Wang et al., 2003</a>). This downregulates the heat shock response during processes stimulated by growth-factors, such as cellular proliferation.",S303,P38532,"8940068, 12917326",2ldu6242,HSF1,"In response to growth factors, MAPK phosphorylates HSF1 at S307, which primes GSK3 to phosphorylate at S303 (<a href='http://pubmed.org/pubmed/8940068' target='_blank' title='Open in PubMed'>Chu et al., 1996</a>). This promotes 14-3-3 binding, sequestering HSF1 in the cytoplasm and thus repressing its transcriptional activity (<a href='http://pubmed.org/pubmed/12917326' target='_blank' title='Open in PubMed'>Wang et al., 2003</a>). This downregulates the heat shock response during processes stimulated by growth-factors, such as cellular proliferation.",S307,P38532,"8940068, 12917326",2ldu6246,HSF1,"In response to stresses such as heat shock, mTORC1 phosphorylates HSF1 at S326, leading to the upregulation of heat-shock proteins such as Hsp70 (<a href='http://pubmed.org/pubmed/22768106' target='_blank' title='Open in PubMed'>Chou et al., 2012</a>).",S326,P38532,22768106,2ldu10671,Hsl,"PKA phosphorylates HSL at several residues (<a href='http://pubmed.org/pubmed/9417067' target='_blank' title='Open in PubMed'>Anthonsen et al., 1998</a>; <a href='http://pubmed.org/pubmed/19018281' target='_blank' title='Open in PubMed'>Krintel et al., 2008</a>), including S557 and S559. This results in activation of HSL, promoting lipolysis and thus mobilisation of energy stores during exercise or starvation.",S559,Q8CDI9,"9417067, 19018281",10670,Hsl,"PKA phosphorylates HSL at several residues (<a href='http://pubmed.org/pubmed/9417067' target='_blank' title='Open in PubMed'>Anthonsen et al., 1998</a>; <a href='http://pubmed.org/pubmed/19018281' target='_blank' title='Open in PubMed'>Krintel et al., 2008</a>), including S557 and S559. This results in activation of HSL, promoting lipolysis and thus mobilisation of energy stores during exercise or starvation.",S557,Q8CDI9,2537200,37334,InsR,"Upon binding insulin, the insulin receptor phosphorylates itself at several residues (<a href='http://pubmed.org/pubmed/2449432' target='_blank' title='Open in PubMed'>White et al., 1988</a>; <a href='http://pubmed.org/pubmed/3166375' target='_blank' title='Open in PubMed'>Tavaré & Denton, 1988</a>; <a href='http://pubmed.org/pubmed/2158467' target='_blank' title='Open in PubMed'>Kruszynska et al., 1990</a>), leading to its activation (<a href='http://pubmed.org/pubmed/1658004' target='_blank' title='Open in PubMed'>Murakami & Rosen, 1991</a>) and stimulation of insulin-responsive pathways, such as glucose uptake in fat and muscle.",Y1175,Q60751,"2449432, 3166375, 2158467, 1658004",1m7n37335,InsR,"Upon binding insulin, the insulin receptor phosphorylates itself at several residues (<a href='http://pubmed.org/pubmed/2449432' target='_blank' title='Open in PubMed'>White et al., 1988</a>; <a href='http://pubmed.org/pubmed/3166375' target='_blank' title='Open in PubMed'>Tavaré & Denton, 1988</a>; <a href='http://pubmed.org/pubmed/2158467' target='_blank' title='Open in PubMed'>Kruszynska et al., 1990</a>), leading to its activation (<a href='http://pubmed.org/pubmed/1658004' target='_blank' title='Open in PubMed'>Murakami & Rosen, 1991</a>) and stimulation of insulin-responsive pathways, such as glucose uptake in fat and muscle.",Y1179,Q60751,"2449432, 3166375, 2158467, 1658004",1m7n37336,InsR,"Upon binding insulin, the insulin receptor phosphorylates itself at several residues (<a href='http://pubmed.org/pubmed/2449432' target='_blank' title='Open in PubMed'>White et al., 1988</a>; <a href='http://pubmed.org/pubmed/3166375' target='_blank' title='Open in PubMed'>Tavaré & Denton, 1988</a>; <a href='http://pubmed.org/pubmed/2158467' target='_blank' title='Open in PubMed'>Kruszynska et al., 1990</a>), leading to its activation (<a href='http://pubmed.org/pubmed/1658004' target='_blank' title='Open in PubMed'>Murakami & Rosen, 1991</a>) and stimulation of insulin-responsive pathways, such as glucose uptake in fat and muscle.",Y1180,Q60751,"2449432, 3166375, 2158467, 1658004",1m7n23681,Irs1,"Following insulin stimulation, S522 of IRS-1 is phosphorylated, with evidence suggesting that this is mediated by p70S6K (<a href='http://pubmed.org/pubmed/16914728' target='_blank' title='Open in PubMed'>Shah & Hunter, 2006</a>). Phosphorylation at this residue reduces tyrosine phosphorylation of IRS-1 (<a href='http://pubmed.org/pubmed/17579213' target='_blank' title='Open in PubMed'>Giraud et al., 2007</a>). This provides a feedback loop that regulates insulin signaling.",S522,Q543V3,"16914728, 17579213",37636,Irs1,"Upon insulin stimulation, IRS-1 is phosphorylated by the insulin receptor at numerous tyrosine residues. These serve as docking sites for SH2-binding proteins. From the phosphosites shown, Y608 (and Y460 to some extent) bind the p85 subunit of PI3K (<a href='http://pubmed.org/pubmed/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>), mediating the PI3K/Akt pathway; Y891 binds Grb2 to activate Ras/MAPK (<a href='http://pubmed.org/pubmed/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/pubmed/8196603' target='_blank' title='Open in PubMed'>Myers et al., 1994</a>); Y1173 binds SHPTP2 to also activate Ras/MAPK (<a href='http://pubmed.org/pubmed/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/pubmed/7935386' target='_blank' title='Open in PubMed'>Noguchi et al., 1994</a>). Thus, IRS-1 acts as a divergence point, stimulating multiple signaling pathways in response to insulin.",Y891,Q543V3,"7504175, 8196603, 7935386",37639,Irs1,"Upon insulin stimulation, IRS-1 is phosphorylated by the insulin receptor at numerous tyrosine residues. These serve as docking sites for SH2-binding proteins. From the phosphosites shown, Y608 (and Y460 to some extent) bind the p85 subunit of PI3K (<a href='http://pubmed.org/pubmed/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>), mediating the PI3K/Akt pathway; Y891 binds Grb2 to activate Ras/MAPK (<a href='http://pubmed.org/pubmed/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/pubmed/8196603' target='_blank' title='Open in PubMed'>Myers et al., 1994</a>); Y1173 binds SHPTP2 to also activate Ras/MAPK (<a href='http://pubmed.org/pubmed/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/pubmed/7935386' target='_blank' title='Open in PubMed'>Noguchi et al., 1994</a>). Thus, IRS-1 acts as a divergence point, stimulating multiple signaling pathways in response to insulin.",Y460,Q543V3,"7504175, 8196603, 7935386",37640,Irs1,"Upon insulin stimulation, IRS-1 is phosphorylated by the insulin receptor at numerous tyrosine residues. These serve as docking sites for SH2-binding proteins. From the phosphosites shown, Y608 (and Y460 to some extent) bind the p85 subunit of PI3K (<a href='http://pubmed.org/pubmed/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>), mediating the PI3K/Akt pathway; Y891 binds Grb2 to activate Ras/MAPK (<a href='http://pubmed.org/pubmed/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/pubmed/8196603' target='_blank' title='Open in PubMed'>Myers et al., 1994</a>); Y1173 binds SHPTP2 to also activate Ras/MAPK (<a href='http://pubmed.org/pubmed/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/pubmed/7935386' target='_blank' title='Open in PubMed'>Noguchi et al., 1994</a>). Thus, IRS-1 acts as a divergence point, stimulating multiple signaling pathways in response to insulin.",Y608,Q543V3,"7504175, 8196603, 7935386",37643,Irs1,"Upon insulin stimulation, IRS-1 is phosphorylated by the insulin receptor at numerous tyrosine residues. These serve as docking sites for SH2-binding proteins. From the phosphosites shown, Y608 (and Y460 to some extent) bind the p85 subunit of PI3K (<a href='http://pubmed.org/pubmed/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>), mediating the PI3K/Akt pathway; Y891 binds Grb2 to activate Ras/MAPK (<a href='http://pubmed.org/pubmed/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/pubmed/8196603' target='_blank' title='Open in PubMed'>Myers et al., 1994</a>); Y1173 binds SHPTP2 to also activate Ras/MAPK (<a href='http://pubmed.org/pubmed/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/pubmed/7935386' target='_blank' title='Open in PubMed'>Noguchi et al., 1994</a>). Thus, IRS-1 acts as a divergence point, stimulating multiple signaling pathways in response to insulin.",Y1173,Q543V3,"7504175, 8196603, 7935386",1816,Mekk3,"SGK1 phosphorylates MEKK3 (MAP3K3) at S337 (and S166), reducing its kinase activity (<a href='http://pubmed.org/pubmed/12761204' target='_blank' title='Open in PubMed'>Chun et al., 2003</a>). Since MEKK3 regulates the stress-activated (SAPK) and mitogen-activated (MAPK) protein kinase pathways, this provides a way for SGK1 to turn off these pathways, enabling cross-talk between kinase signaling pathways.",S337,Q61084,12761204,2jrh11092,MSK1,"The mitogen- and stress-activated kinase 1 (MSK1) is initially phosphorylated by p38 MAPK and ERK1 (<a href='http://pubmed.org/pubmed/11994045' target='_blank' title='Open in PubMed'>Markou & Lazou, 2002</a>; <a href='http://pubmed.org/pubmed/15568999' target='_blank' title='Open in PubMed'>McCoy et al., 2005</a>), including at residue T645. This enables MSK1 to use its C-terminal kinase domain to autophosphorylate itself at several sites, including the hydrophobic motif at S375. This activates the N-terminal kinase domain, enabling MSK1 to phosphorylate its substrates (<a href='http://pubmed.org/pubmed/15568999' target='_blank' title='Open in PubMed'>McCoy et al., 2005</a>). This allows the cell to respond to both growth factors and cellular stress through the same kinase (e.g., <a href='http://pubmed.org/pubmed/9687510' target='_blank' title='Open in PubMed'>Deak et al., 1998</a>).",S375,Q8C050,"11994045, 15568999, 9687510",3kn511843,mTOR,"Upon activation, mTOR autophosphorylates itself at S2481 (<a href='http://pubmed.org/pubmed/10702316' target='_blank' title='Open in PubMed'>Peterson et al., 2000</a>), being observed in both complexes mTORC1 and mTORC2 (<a href='http://pubmed.org/pubmed/20022946' target='_blank' title='Open in PubMed'>Soliman et al., 2010</a>). Although diagnostic of mTOR activity, the physiological significance of this autophosphorylation site remains elusive.",S2481,Q9JLN9,"10702316, 20022946",2gaq11843a,mTOR,"Upon activation, mTOR autophosphorylates itself at S2481 (<a href='http://pubmed.org/pubmed/10702316' target='_blank' title='Open in PubMed'>Peterson et al., 2000</a>), being observed in both complexes mTORC1 and mTORC2 (<a href='http://pubmed.org/pubmed/20022946' target='_blank' title='Open in PubMed'>Soliman et al., 2010</a>). Although diagnostic of mTOR activity, the physiological significance of this autophosphorylation site remains elusive.",S2481,Q9JLN9,"10702316, 20022946",2gaqwtf2448,mTOR,"Originally considered an Akt target (<a href='http://pubmed.org/pubmed/10910062' target='_blank' title='Open in PubMed'>Sekulić et al., 2000</a>; <a href='http://pubmed.org/pubmed/10567225' target='_blank' title='Open in PubMed'>Navé et al., 1999</a>), more recent evidence suggests that S2448 is actually phosphorylated by p70S6K (<a href='http://pubmed.org/pubmed/15899889' target='_blank' title='Open in PubMed'>Chiang & Abraham, 2005</a>; <a href='http://pubmed.org/pubmed/15905173' target='_blank' title='Open in PubMed'>Holz & Blenis, 2005</a>). This presents a feedback loop, although its function has not been elucidated. Since S2448 lies within the repressor domain, it has been speculated that phosphorylation at this site represses mTOR activity (<a href='http://pubmed.org/pubmed/10910062' target='_blank' title='Open in PubMed'>Sekulić et al., 2000</a>), but does not affect mTORC1 complex formation (<a href='http://pubmed.org/pubmed/19145465' target='_blank' title='Open in PubMed'>Rosner et al., 2010</a>). Please note that although this phosphosite has been placed on the mTORC2 track, it can be found in both mTORC1 and mTORC2 (<a href='http://pubmed.org/pubmed/19145465' target='_blank' title='Open in PubMed'>Rosner et al., 2010</a>).",S2448,Q9JLN9,"10910062, 10567225, 15899889, 15905173, 19145465",2gaq4497,Ndrg1,"SGK kinases phosphorylate T328, S330, T346, T356, and T366 of NDRG1 (the latter three found within a triple 10-residue repeat sequence) (<a href='http://pubmed.org/pubmed/15461589' target='_blank' title='Open in PubMed'>Murray et al., 2004</a>; <a href='http://pubmed.org/pubmed/20416281' target='_blank' title='Open in PubMed'>Murakami et al., 2010</a>). This primes NDRG1 for phosphorylation by GSK3 (<a href='http://pubmed.org/pubmed/15461589' target='_blank' title='Open in PubMed'>Murray et al., 2004</a>). Phosphorylation of NDRG1 influences its role in stress responses, such as the suppression of NF-kB signaling and CXC chemokine production (<a href='http://pubmed.org/pubmed/20416281' target='_blank' title='Open in PubMed'>Murakami et al., 2010</a>).",S330,Q62433,"15461589, 20416281",2xmr31569,Ndrg1,"SGK kinases phosphorylate T328, S330, T346, T356, and T366 of NDRG1 (the latter three found within a triple 10-residue repeat sequence) (<a href='http://pubmed.org/pubmed/15461589' target='_blank' title='Open in PubMed'>Murray et al., 2004</a>; <a href='http://pubmed.org/pubmed/20416281' target='_blank' title='Open in PubMed'>Murakami et al., 2010</a>). This primes NDRG1 for phosphorylation by GSK3 (<a href='http://pubmed.org/pubmed/15461589' target='_blank' title='Open in PubMed'>Murray et al., 2004</a>). Phosphorylation of NDRG1 influences its role in stress responses, such as the suppression of NF-kB signaling and CXC chemokine production (<a href='http://pubmed.org/pubmed/20416281' target='_blank' title='Open in PubMed'>Murakami et al., 2010</a>).",T366,Q62433,"15461589, 20416281",2xmr32167,Ndrg2,"SGK kinases phosphorylate T330, S332, and T348 of NDRG2 - there is some evidence that this primes NDRG2 for phosphorylation by GSK3 (<a href='http://pubmed.org/pubmed/15461589' target='_blank' title='Open in PubMed'>Murray et al., 2004</a>). The functional consequences of this have not been well-studied.",T330,Q9QYG0,15461589,2qmq32169,Ndrg2,"SGK kinases phosphorylate T330, S332, and T348 of NDRG2 - there is some evidence that this primes NDRG2 for phosphorylation by GSK3 (<a href='http://pubmed.org/pubmed/15461589' target='_blank' title='Open in PubMed'>Murray et al., 2004</a>). The functional consequences of this have not been well-studied.",T348,Q9QYG0,15461589,2qmq34999,p70S6K,"mTORC1 phosphorylates p70S6K at T412 (<a href='http://pubmed.org/pubmed/7489717' target='_blank' title='Open in PubMed'>Pearson et al., 1995</a>; <a href='http://pubmed.org/pubmed/7545671' target='_blank' title='Open in PubMed'>Han et al., 1995</a>), found within a hydrophobic motif downstream of the catalytic domain. This promotes p70S6K to phosphorylate numerous proteins (e.g., eIF4B) to initiate protein synthesis. As pT412 was absent in our phosphoproteomic dataset (<a href='http://pubmed.org/pubmed/23684622' target='_blank' title='Open in PubMed'>Humphrey et al., 2013</a>), for illustrative purposes we have used data on pT444, both of which are mTORC1-regulated sites (<a href='http://pubmed.org/pubmed/21659604' target='_blank' title='Open in PubMed'>Hsu et al., 2011</a>) and respond with similar kinetics to insulin in adipocytes (<a href='http://pubmed.org/pubmed/23684622' target='_blank' title='Open in PubMed'>Humphrey et al., 2013</a>).",T412,Q8BSK8,"7489717, 7545671, 9632736",4l451212,p90RSK,"MAPK/ERK phosphorylates p90RSK at several residues, including S352 (human S363) (<a href='http://pubmed.org/pubmed/9430688' target='_blank' title='Open in PubMed'>Dalby et al., 1998</a>). This residue is found within the N-terminal kinase domain, contributing to the activation of p90RSK.",S352,Q3TIM6,9430688,25879,Pde3b,"Promotes 14-3-3 binding and increased Pde3b activity (<a href='http://pubmed.org/pubmed/10454575' target='_blank' title='Open in PubMed'>Kitamura et al., 1999</a>; <a href='http://pubmed.org/pubmed/12453887' target='_blank' title='Open in PubMed'>Onuma et al., 2002</a>). Pde3b catalyses hydrolysis of cAMP, influencing cAMP-dependent processes. For instance, this deactivates hormone-sensitive lipase (HSL) and lipolysis in adipocytes.",S273,B2RWU9,"10454575, 12453887",7476,Pfkfb2,"There is strong evidence to suggest that PFKFB2 (heart PFK-2) is phosphorylated at S469 and S486 by Akt, leading to 14-3-3 binding and increased activity (<a href='http://pubmed.org/pubmed/9211863' target='_blank' title='Open in PubMed'>Deprez et al., 1997</a>; <a href='http://pubmed.org/pubmed/12853467' target='_blank' title='Open in PubMed'>Pozuelo et al., 2003</a>; <a href='http://pubmed.org/pubmed/20958264' target='_blank' title='Open in PubMed'>Moon et al., 2011</a>). This elevates levels of its product, fructose-2,6-bisphosphate, which stimulates glycolysis.",S469,P70265,"9211863, 12853467, 20958264",1fbt7477,Pfkfb2,"There is strong evidence to suggest that PFKFB2 (heart PFK-2) is phosphorylated at S469 and S486 by Akt, leading to 14-3-3 binding and increased activity (<a href='http://pubmed.org/pubmed/9211863' target='_blank' title='Open in PubMed'>Deprez et al., 1997</a>; <a href='http://pubmed.org/pubmed/12853467' target='_blank' title='Open in PubMed'>Pozuelo et al., 2003</a>; <a href='http://pubmed.org/pubmed/20958264' target='_blank' title='Open in PubMed'>Moon et al., 2011</a>). This elevates levels of its product, fructose-2,6-bisphosphate, which stimulates glycolysis.",S486,P70265,"9211863, 12853467, 20958264",1fbt9506,Plin1,"Promotes the access of lipases to lipid droplets in adipocytes, leading to lipid droplet breakdown and lipolysis (<a href='http://pubmed.org/pubmed/16488886' target='_blank' title='Open in PubMed'>Marcinkiewicz et al., 2006</a>; <a href='http://pubmed.org/pubmed/17114792' target='_blank' title='Open in PubMed'>Miyoshi et al., 2007</a>). This serves to mobilise energy during fasting and exercise.",S492,Q8CGN5,"16488886, 17114792",6505,Pras40,"Akt phosphorylates PRAS40 at T247 (<a href='http://pubmed.org/pubmed/12524439' target='_blank' title='Open in PubMed'>Kovacina et al., 2003</a>; <a href='http://pubmed.org/pubmed/17386266' target='_blank' title='Open in PubMed'>Sancak et al., 2007</a>; <a href='http://pubmed.org/pubmed/17277771' target='_blank' title='Open in PubMed'>Vander et al., 2007</a>), which promotes mTORC1 to phosphorylate PRAS40 at multiple sites, including S184 (<a href='http://pubmed.org/pubmed/20138985' target='_blank' title='Open in PubMed'>Nascimento et al., 2010</a>; <a href='http://pubmed.org/pubmed/17517883' target='_blank' title='Open in PubMed'>Oshiro et al., 2007</a>). Together, these phosphorylation events cause PRAS40 to dissociate from mTORC1 and bind 14-3-3. Combined with Akt-mediated TSC2 phosphorylation, this results in mTORC1 activation.",S184,Q9D1F4,"12524439, 17386266, 17277771, 17517883, 20138985",32018,Pras40,"Akt phosphorylates PRAS40 at T247 (<a href='http://pubmed.org/pubmed/12524439' target='_blank' title='Open in PubMed'>Kovacina et al., 2003</a>; <a href='http://pubmed.org/pubmed/17386266' target='_blank' title='Open in PubMed'>Sancak et al., 2007</a>; <a href='http://pubmed.org/pubmed/17277771' target='_blank' title='Open in PubMed'>Vander et al., 2007</a>), which promotes mTORC1 to phosphorylate PRAS40 at multiple sites, including S184 (<a href='http://pubmed.org/pubmed/20138985' target='_blank' title='Open in PubMed'>Nascimento et al., 2010</a>; <a href='http://pubmed.org/pubmed/17517883' target='_blank' title='Open in PubMed'>Oshiro et al., 2007</a>). Together, these phosphorylation events cause PRAS40 to dissociate from mTORC1 and bind 14-3-3. Combined with Akt-mediated TSC2 phosphorylation, this results in mTORC1 activation.",T247,Q9D1F4,"12524439, 17386266, 17277771, 17517883, 20138985",1143,Rps6,"p70S6K phosphorylates RPS6 (S6), a component of the 40S ribosomal subunit, at several sites, including S236 and S240 (<a href='http://pubmed.org/pubmed/1939282' target='_blank' title='Open in PubMed'>Ferrari et al., 1991</a>). Some studies indicate that this results in selective translation of a subset of mRNAs, 5'TOP mRNAs, (e.g., <a href='http://pubmed.org/pubmed/9218810' target='_blank' title='Open in PubMed'>Jefferies et al., 1997</a>), but this remains controversial (e.g., <a href='http://pubmed.org/pubmed/11972328' target='_blank' title='Open in PubMed'>Barth-Baus et al., 2002</a>; <a href='http://pubmed.org/pubmed/16166381' target='_blank' title='Open in PubMed'>Ruvinsky et al., 2005</a>). There is also evidence that phosphorylation promotes binding to the 7-methylguanosine cap-binding complex to initiate translation (<a href='http://pubmed.org/pubmed/17360704' target='_blank' title='Open in PubMed'>Roux et al., 2007</a>), but studies have also shown that phosphorylation reduces protein synthesis, slows cell division, and increases cell size (e.g., <a href='http://pubmed.org/pubmed/16166381' target='_blank' title='Open in PubMed'>Ruvinsky et al., 2005</a>). Thus, the physiological outcome of S6 phosphorylation remains unclear.",S236,P62754,1939282,3j161144,Rps6,"p70S6K phosphorylates RPS6 (S6), a component of the 40S ribosomal subunit, at several sites, including S236 and S240 (<a href='http://pubmed.org/pubmed/1939282' target='_blank' title='Open in PubMed'>Ferrari et al., 1991</a>). Some studies indicate that this results in selective translation of a subset of mRNAs, 5'TOP mRNAs, (e.g., <a href='http://pubmed.org/pubmed/9218810' target='_blank' title='Open in PubMed'>Jefferies et al., 1997</a>), but this remains controversial (e.g., <a href='http://pubmed.org/pubmed/11972328' target='_blank' title='Open in PubMed'>Barth-Baus et al., 2002</a>; <a href='http://pubmed.org/pubmed/16166381' target='_blank' title='Open in PubMed'>Ruvinsky et al., 2005</a>). There is also evidence that phosphorylation promotes binding to the 7-methylguanosine cap-binding complex to initiate translation (<a href='http://pubmed.org/pubmed/17360704' target='_blank' title='Open in PubMed'>Roux et al., 2007</a>), but studies have also shown that phosphorylation reduces protein synthesis, slows cell division, and increases cell size (e.g., <a href='http://pubmed.org/pubmed/16166381' target='_blank' title='Open in PubMed'>Ruvinsky et al., 2005</a>). Thus, the physiological outcome of S6 phosphorylation remains unclear.",S240,P62754,1939282,3j1632613,Sin1,"Akt phosphorylates SIN1, a component of the mTORC2 complex. This activates mTORC2 - amongst its substrates is Akt, thus potentiating a feed-forward signaling loop (<a href='http://pubmed.org/pubmed/23684622' target='_blank' title='Open in PubMed'>Humphrey et al., 2013</a>).",T86,Q8BKH7,23684622,3voq12994,SOS1,"MAP kinase (MAPK/ERK) phosphorylates SOS1 at several residues, including S1179 and S1183, which causes dissociation of the Sos1-Grb2 complex (<a href='http://pubmed.org/pubmed/8816480' target='_blank' title='Open in PubMed'>Corbalan-Garcia et al., 1996</a>). Since Sos1-Grb2 connects receptor tyrosine kinases to Ras and MAPK downstream, this serves as a feedback mechanism for Ras/MAPK signaling (e.g., <a href='http://pubmed.org/pubmed/7829473' target='_blank' title='Open in PubMed'>Cherniack et al., 1995</a>).",S1179,Q62245,8816480,1pms12995,SOS1,"MAP kinase (MAPK/ERK) phosphorylates SOS1 at several residues, including S1179 and S1183, which causes dissociation of the Sos1-Grb2 complex (<a href='http://pubmed.org/pubmed/8816480' target='_blank' title='Open in PubMed'>Corbalan-Garcia et al., 1996</a>). Since Sos1-Grb2 connects receptor tyrosine kinases to Ras and MAPK downstream, this serves as a feedback mechanism for Ras/MAPK signaling (e.g., <a href='http://pubmed.org/pubmed/7829473' target='_blank' title='Open in PubMed'>Cherniack et al., 1995</a>).",S1183,Q62245,8816480,1pms3943,TAK1,"Protein kinase A (PKA) phosphorylates TAK1 at S439. This allows cAMP/PKA-dependent signals, such as prostaglandin E2, to enhance downstream signaling pathways, including MAPK and NF-kB, subsequently promoting osteoclast differentiation (<a href='http://pubmed.org/pubmed/15647289' target='_blank' title='Open in PubMed'>Kobayashi et al., 2005</a>). This is in concordance with the role that TAK1 plays in directing differentiation away from adipogenesis (<a href='http://pubmed.org/pubmed/12598905' target='_blank' title='Open in PubMed'>Suzawa et al., 2003</a>).",S439,Q3TXG1,15647289,11430,TSC2,"Akt phosphorylates TSC2 at several sites, including S939, S981 and T1465 (<a href='http://pubmed.org/pubmed/12150915' target='_blank' title='Open in PubMed'>Manning et al., 2002</a>; <a href='http://pubmed.org/pubmed/12172553' target='_blank' title='Open in PubMed'>Inoki et al., 2002</a>; <a href='http://pubmed.org/pubmed/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>). Whilst there is conflicting evidence about whether this affects its interaction with binding partner TSC1 (e.g., <a href='http://pubmed.org/pubmed/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>) or the stability of TSC2 itself (<a href='http://pubmed.org/pubmed/12172553' target='_blank' title='Open in PubMed'>Inoki et al., 2002</a>; <a href='http://pubmed.org/pubmed/12167664' target='_blank' title='Open in PubMed'>Dan et al., 2002</a>), studies suggest TSC2 phosphorylation promotes 14-3-3 binding and its dissociation from the lysosome (<a href='http://pubmed.org/pubmed/12438239' target='_blank' title='Open in PubMed'>Liu et al., 2002</a>; <a href='http://pubmed.org/pubmed/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>; <a href='http://pubmed.org/pubmed/24529379' target='_blank' title='Open in PubMed'>Menon et al., 2014</a>). This uncouples TSC2 from its substrate, GTP-binding protein Rheb, an mTORC1 activator (<a href='http://pubmed.org/pubmed/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>; <a href='http://pubmed.org/pubmed/24529379' target='_blank' title='Open in PubMed'>Menon et al., 2014</a>). This ultimately derepresses Rheb, facilitating its GTP loading, and subsequently activates mTORC1, promoting protein and lipid synthesis in response to mitogenic and nutrient stimuli.",S981,Q61037,,3brw11441,TSC2,"Akt phosphorylates TSC2 at several sites, including S939, S981 and T1465 (<a href='http://pubmed.org/pubmed/12150915' target='_blank' title='Open in PubMed'>Manning et al., 2002</a>; <a href='http://pubmed.org/pubmed/12172553' target='_blank' title='Open in PubMed'>Inoki et al., 2002</a>; <a href='http://pubmed.org/pubmed/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>). Whilst there is conflicting evidence about whether this affects its interaction with binding partner TSC1 (e.g., <a href='http://pubmed.org/pubmed/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>) or the stability of TSC2 itself (<a href='http://pubmed.org/pubmed/12172553' target='_blank' title='Open in PubMed'>Inoki et al., 2002</a>; <a href='http://pubmed.org/pubmed/12167664' target='_blank' title='Open in PubMed'>Dan et al., 2002</a>), studies suggest TSC2 phosphorylation promotes 14-3-3 binding and its dissociation from the lysosome (<a href='http://pubmed.org/pubmed/12438239' target='_blank' title='Open in PubMed'>Liu et al., 2002</a>; <a href='http://pubmed.org/pubmed/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>; <a href='http://pubmed.org/pubmed/24529379' target='_blank' title='Open in PubMed'>Menon et al., 2014</a>). This uncouples TSC2 from its substrate, GTP-binding protein Rheb, an mTORC1 activator (<a href='http://pubmed.org/pubmed/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>; <a href='http://pubmed.org/pubmed/24529379' target='_blank' title='Open in PubMed'>Menon et al., 2014</a>). This ultimately derepresses Rheb, facilitating its GTP loading, and subsequently activates mTORC1, promoting protein and lipid synthesis in response to mitogenic and nutrient stimuli.",S939,Q61037,,3brw33125,TSC2,"Akt phosphorylates TSC2 at several sites, including S939, S981 and T1465 (<a href='http://pubmed.org/pubmed/12150915' target='_blank' title='Open in PubMed'>Manning et al., 2002</a>; <a href='http://pubmed.org/pubmed/12172553' target='_blank' title='Open in PubMed'>Inoki et al., 2002</a>; <a href='http://pubmed.org/pubmed/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>). Whilst there is conflicting evidence about whether this affects its interaction with binding partner TSC1 (e.g., <a href='http://pubmed.org/pubmed/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>) or the stability of TSC2 itself (<a href='http://pubmed.org/pubmed/12172553' target='_blank' title='Open in PubMed'>Inoki et al., 2002</a>; <a href='http://pubmed.org/pubmed/12167664' target='_blank' title='Open in PubMed'>Dan et al., 2002</a>), studies suggest TSC2 phosphorylation promotes 14-3-3 binding and its dissociation from the lysosome (<a href='http://pubmed.org/pubmed/12438239' target='_blank' title='Open in PubMed'>Liu et al., 2002</a>; <a href='http://pubmed.org/pubmed/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>; <a href='http://pubmed.org/pubmed/24529379' target='_blank' title='Open in PubMed'>Menon et al., 2014</a>). This uncouples TSC2 from its substrate, GTP-binding protein Rheb, an mTORC1 activator (<a href='http://pubmed.org/pubmed/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>; <a href='http://pubmed.org/pubmed/24529379' target='_blank' title='Open in PubMed'>Menon et al., 2014</a>). This ultimately derepresses Rheb, facilitating its GTP loading, and subsequently activates mTORC1, promoting protein and lipid synthesis in response to mitogenic and nutrient stimuli.",T1465,Q61037,,3brw21925,ULK1,"mTORC1 phosphorylates Ulk1 at S757, which affects the interaction between Ulk1 and AMPK (<a href='http://pubmed.org/pubmed/21258367' target='_blank' title='Open in PubMed'>Kim et al., 2011</a>; <a href='http://pubmed.org/pubmed/21383122' target='_blank' title='Open in PubMed'>Shang et al., 2011</a>). Although there is conflicting evidence about the direction and effect of this interaction, there is a consensus that this prevents autophagy when nutrients are not limiting.",S757,O70405,"21258367, 21383122",2hak17539,NHE1,"Promotes 14-3-3 binding and increased Na+/H+ exchange, which leads to cell alkalinization (<a href='http://pubmed.org/pubmed/10400637' target='_blank' title='Open in PubMed'>Takahashi et al., 1999</a>; <a href='http://pubmed.org/pubmed/11279064' target='_blank' title='Open in PubMed'>Lehoux et al., 2001</a>). Whilst this has been shown to exacerbate myocardial ischemia and reperfusion injury (<a href='http://pubmed.org/pubmed/16717153' target='_blank' title='Open in PubMed'>Maekawa et al., 2006</a>), it may also be necessary for cell cycle progression (<a href='http://pubmed.org/pubmed/19622752' target='_blank' title='Open in PubMed'>Meima et al., 2009</a>).",S707,Q61165,10400637,wtfPras40,PRAS40,"To the best of our knowledge, this site is not well-characterized in the literature and thus the consequences of phosphorylating this site are not clear.",S159,Q9D1F4,,13015,SOS1,"To the best of our knowledge, this site is not well-characterized in the literature and thus the consequences of phosphorylating this site are not clear.",S1196,Q62245,,1pms13015a,SOS1,"To the best of our knowledge, this site is not well-characterized in the literature and thus the consequences of phosphorylating this site are not clear.",S1196,Q62245,,1pms